Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 18 04:00PM ET
5.58
Dollar change
+0.43
Percentage change
8.35
%
Index- P/E- EPS (ttm)-11.89 Insider Own16.17% Shs Outstand4.79M Perf Week1.09%
Market Cap26.74M Forward P/E- EPS next Y-7.39 Insider Trans0.00% Shs Float4.02M Perf Month78.85%
Income-24.76M PEG- EPS next Q-5.34 Inst Own31.22% Short Float8.90% Perf Quarter-57.33%
Sales34.75M P/S0.77 EPS this Y82.75% Inst Trans0.68% Short Ratio0.25 Perf Half Y-66.91%
Book/sh-25.16 P/B- EPS next Y25.85% ROA-28.89% Short Interest0.36M Perf Year-92.38%
Cash/sh5.98 P/C0.93 EPS next 5Y53.59% ROE-1715.20% 52W Range2.37 - 98.75 Perf YTD-48.09%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-94.35% Beta-0.68
Dividend TTM- Quick Ratio2.09 Sales past 5Y-5.58% Gross Margin71.80% 52W Low135.75% ATR (14)1.29
Dividend Ex-Date- Current Ratio2.33 EPS Y/Y TTM87.95% Oper. Margin-168.66% RSI (14)47.14 Volatility12.57% 23.56%
Employees252 Debt/Eq- Sales Y/Y TTM11.53% Profit Margin-71.24% Recom1.50 Target Price28.67
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q74.10% Payout- Rel Volume0.79 Prev Close5.15
Sales Surprise-37.23% EPS Surprise23.29% Sales Q/Q-70.51% EarningsNov 13 BMO Avg Volume1.41M Price5.58
SMA200.49% SMA50-19.48% SMA200-72.29% Trades Volume1,118,885 Change8.35%
Date Action Analyst Rating Change Price Target Change
Nov-14-24Downgrade Chardan Capital Markets Buy → Neutral
Oct-02-24Initiated TD Cowen Buy $2
Sep-06-24Initiated ROTH MKM Buy $2
Feb-09-24Initiated Jefferies Buy $5
Today 08:30AM
Feb-13-25 08:30AM
Feb-10-25 09:55AM
Jan-24-25 04:15PM
11:28AM
10:32AM Loading…
10:32AM
09:30AM
Jan-23-25 03:48PM
Jan-21-25 08:30AM
Jan-14-25 09:18AM
Jan-08-25 08:00AM
Dec-24-24 07:00AM
Dec-19-24 03:57PM
Dec-02-24 08:00AM
Nov-25-24 02:51PM
02:51PM Loading…
02:51PM
08:00AM
Nov-13-24 08:00AM
Nov-04-24 08:10AM
Oct-30-24 08:30AM
Oct-23-24 08:00AM
Oct-09-24 08:00AM
Oct-01-24 08:04AM
Sep-05-24 05:30PM
08:00AM
Sep-03-24 08:00AM
Aug-28-24 08:28AM
Aug-20-24 08:00AM
Aug-15-24 04:05PM
Aug-13-24 08:00AM
04:05PM Loading…
Jul-16-24 04:05PM
Jun-28-24 09:06AM
Jun-26-24 08:36AM
Jun-20-24 03:49PM
08:00AM
Jun-14-24 01:44PM
Jun-11-24 10:50AM
09:35AM
08:00AM
Jun-05-24 08:00AM
May-30-24 08:00AM
May-29-24 04:05PM
May-15-24 08:00AM
May-14-24 12:53PM
08:00AM
May-02-24 08:00AM
Apr-30-24 08:30AM
Apr-17-24 08:31AM
Apr-04-24 08:00AM
Mar-21-24 12:53PM
08:00AM
Mar-13-24 08:30AM
Mar-12-24 08:00AM
Mar-04-24 08:30AM
Feb-20-24 04:05PM
Feb-08-24 08:30AM
Jan-29-24 08:00AM
Jan-23-24 09:04AM
08:15AM
Jan-17-24 08:00AM
Jan-11-24 08:00AM
Jan-08-24 08:00AM
Jan-05-24 08:00AM
Jan-02-24 08:00AM
Nov-13-23 08:00AM
Nov-06-23 04:05PM
08:00AM
Oct-11-23 08:00AM
Oct-04-23 08:00AM
Sep-18-23 08:00AM
Aug-29-23 08:00AM
Aug-28-23 08:00AM
Aug-04-23 01:33PM
Allurion Technologies, Inc. develops treatments for obesity. The Allurion Program is a weight loss platform that combines the Allurion Gastric Balloon, a swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The company was founded on January 25, 2023 and is headquartered in Natick, MA.